blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1414492

EP1414492 - METHOD FOR TREATING MULTIPLE MYELOMA [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.09.2008
Database last updated on 15.06.2024
Most recent event   Tooltip13.08.2010Lapse of the patent in a contracting state
New state(s): TR		published on 15.09.2010  [2010/37]
Applicant(s)For all designated states
Immune System Therapeutics Ltd
Level 8 235 Jones Street
Ultimo NSW 2007 / AU
[2007/47]
Former [2006/30]For all designated states
Pacmab Ltd
University of Technology, Sydney Room 33b, Level 6 UTS Building 4 95 Thomas St.
Broadway, NSW 2007 / AU
Former [2006/28]For all designated states
Pacmab PTY Ltd, University of Technology, Sydney
Room 33b, Level 6 UTS Building 4 95 Thomas St.
Broadway, NSW 2007 / AU
Former [2004/19]For all designated states
Pacmab PTY Ltd, University of Technology, Sydney
Room 1.01, Level 1, Dunbar Building, Westbourne Street
Gore Hill, New South Wales 2065 / AU
Inventor(s)01 / RAISON, Robert, Lindsay
15 Lilla Road
Pennant Hills, New South Wales 2120 / AU
02 / DUNN, Rosanne, Dorothy
93A Seaforth Crescent
Seaforth, New South Wales 2092 / AU
03 / CHOO, Boon Hwa Andre
Block 288G, Bukit Batok Street 25
12-238, 656288 Singapore / SG
 [2004/19]
Representative(s)Cornish, Kristina Victoria Joy, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2004/19]Cornish, Kristina Victoria Joy, et al
Kilburn & Strode, 20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date02742531.305.07.2002
[2004/19]
WO2002AU00896
Priority number, dateAU2001PR0617906.07.2001         Original published format: AU PR617901
[2004/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03004056
Date:16.01.2003
Language:EN
[2003/03]
Type: A1 Application with search report 
No.:EP1414492
Date:06.05.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 16.01.2003 takes the place of the publication of the European patent application.
[2004/19]
Type: B1 Patent specification 
No.:EP1414492
Date:21.11.2007
Language:EN
[2007/47]
Search report(s)International search report - published on:AU16.01.2003
(Supplementary) European search report - dispatched on:EP04.11.2005
ClassificationIPC:A61K39/395, A61K39/44, A61P35/00, A61P35/02, A61P37/06
[2004/19]
CPC:
C07K16/4283 (EP,US); A61P19/00 (EP); A61P35/00 (EP);
A61P35/02 (EP); A61P37/06 (EP); A61P43/00 (EP);
C07K16/3061 (EP,US); A61K2039/505 (EP,US); C07K2317/24 (EP,US);
C07K2317/73 (EP,US); C07K2319/00 (EP,US); Y10S424/80 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/19]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:VERFAHREN ZUR BEHANDLUNG VON MULTIPLEM MYELOM[2004/19]
English:METHOD FOR TREATING MULTIPLE MYELOMA[2004/19]
French:METHODE DE TRAITEMENT DU MYELOME MULTIPLE[2004/19]
Entry into regional phase06.02.2004National basic fee paid 
06.02.2004Search fee paid 
06.02.2004Designation fee(s) paid 
06.02.2004Examination fee paid 
Examination procedure20.01.2003Request for preliminary examination filed
International Preliminary Examining Authority: AU
06.02.2004Examination requested  [2004/19]
18.03.2004Amendment by applicant (claims and/or description)
18.07.2006Despatch of a communication from the examining division (Time limit: M04)
28.11.2006Reply to a communication from the examining division
22.12.2006Despatch of a communication from the examining division (Time limit: M02)
26.02.2007Reply to a communication from the examining division
08.05.2007Communication of intention to grant the patent
12.09.2007Fee for grant paid
12.09.2007Fee for publishing/printing paid
Opposition(s)22.08.2008No opposition filed within time limit [2008/44]
Fees paidRenewal fee
06.02.2004Renewal fee patent year 03
13.07.2005Renewal fee patent year 04
12.07.2006Renewal fee patent year 05
13.07.2007Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY21.11.2007
CZ21.11.2007
EE21.11.2007
FI21.11.2007
SK21.11.2007
TR21.11.2007
BG21.02.2008
PT21.04.2008
[2010/37]
Former [2009/33]CY21.11.2007
CZ21.11.2007
EE21.11.2007
FI21.11.2007
SK21.11.2007
BG21.02.2008
PT21.04.2008
Former [2009/22]CZ21.11.2007
EE21.11.2007
FI21.11.2007
SK21.11.2007
BG21.02.2008
PT21.04.2008
Former [2008/42]CZ21.11.2007
FI21.11.2007
SK21.11.2007
BG21.02.2008
PT21.04.2008
Former [2008/39]CZ21.11.2007
FI21.11.2007
SK21.11.2007
BG21.02.2008
Former [2008/36]CZ21.11.2007
FI21.11.2007
BG21.02.2008
Former [2008/25]FI21.11.2007
BG21.02.2008
Documents cited:Search   [ ] - No further relevant documents disclosed
International search[X]  - WALKER M. ET AL., "A monoclonal antibody with selectivity for human kappa myeloma and lymphoma cells which has potential as a therapeutic agent", ADV. EXP. MED. BIOL., (1985), vol. 186, pages 833 - 841, XP008030775
 [X]  - BOUX H. ET AL., "A tumor associated antigen specific for kappa myeloma cells", J. EXP. MED., (1983), vol. 158, no. 5, pages 1769 - 1774, XP001191239

DOI:   http://dx.doi.org/10.1084/jem.158.5.1769
 [X]  - DUNN R. ET AL., "Antigen binding and cytotoxic properties of a recombinant immunotoxin incorporating the lytic peptide, melittin", IMMUNOTECHNOLOGY, (1996), vol. 2, no. 3, pages 229 - 240, XP000653171

DOI:   http://dx.doi.org/10.1016/S1380-2933(96)00055-3
 [X]  - IZARD M. ET AL., "An improved method for labeling monoclonal antibodies with samarium-153: use of the bifunctional chelate 2-(p-isothiocyanatobenzyl)-6-methyldiethylenetriaminepentaacetic acid", BIOCONJUGATE CHEM., (1992), vol. 3, no. 4, pages 346 - 350, XP001191135

DOI:   http://dx.doi.org/10.1021/bc00016a015
 [X]  - WALKER K. ET AL., "A rat model system for radioimmunodetection of kappa myeloma antigen on malignant B cells", EUROP. J. MED., (1986), vol. 12, no. 9, pages 461 - 467, XP008030786
 [X]  - WESTON K. ET AL., "In vivo binding of mouse IgG via polyreactive surface IgM abrogates progressive lymphocytosis in prolymphocytic leukemia", LEUKEMIA AND LYMPHOMA, (1998), vol. 29, pages 361 - 373, XP008030785
Examination   - MAYNARD JENNIFER A; ET AL, "Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity", NATURE BIOTECHNOLOGY, (200206), vol. 20, no. 6, pages 597 - 601, XP002390004

DOI:   http://dx.doi.org/10.1038/nbt0602-597
    - MEJÍAS ASUNCIÓN ET AL., "Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: Time versus potency", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, (200511), vol. 49, no. 11, pages 4700 - 4707
    - RAJPAL A ET AL., "A general method for greatly improving the affinity of antibodies by using combinatorial libraries", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, (200506), vol. 102, no. 24, pages 8466 - 8471, XP002347095

DOI:   http://dx.doi.org/10.1073/pnas.0503543102
    - LÜHDER F; ET AL, "Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists", JOURNAL OF EXPERIMENTAL MEDICINE, TOKYO; JP, (20030421), vol. 197, no. 8, pages 955 - 966, XP002261827

DOI:   http://dx.doi.org/10.1084/jem.20021024
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.